Literature DB >> 10431814

Functional consequences of amyloidosis mutation for gelsolin polypeptide -- analysis of gelsolin-actin interaction and gelsolin processing in gelsolin knock-out fibroblasts.

H Kangas1, I Ulmanen, T Paunio, D J Kwiatkowski, M Lehtovirta, A Jalanko, L Peltonen.   

Abstract

Gelsolin, an actin-modulating protein, derived from a single gene exists in intracellular and secreted forms. A point mutation at position 187 of both forms of gelsolin causes familial amyloidosis of the Finnish type (FAF). Here, we expressed both isoforms of the wild-type and FAF mutant gelsolin in mouse embryonic gelsolin-null fibroblasts. We demonstrate that the FAF mutation does not interfere with the normal actin-modulating function of intracellular gelsolin, and that aberrant processing of secreted FAF gelsolin to FAF amyloid precursor takes place in the gelsolin-negative background. These results suggest that, in patients with FAF, symptoms are caused by the accumulation in their tissues of amyloid derived from plasma gelsolin and are not due to functional differences in cytoplasmic gelsolin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10431814     DOI: 10.1016/s0014-5793(99)00790-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  3 in total

1.  Metalloendoprotease cleavage triggers gelsolin amyloidogenesis.

Authors:  Lesley J Page; Ji Young Suk; Mary E Huff; Hee-Jong Lim; John Venable; John Yates; Jeffery W Kelly; William E Balch
Journal:  EMBO J       Date:  2005-11-10       Impact factor: 11.598

2.  Calcium-dependent conformational stability of modules 1 and 2 of human gelsolin.

Authors:  A Zapun; S Grammatyka; G Déral; T Vernet
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

3.  Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca(2+) stabilization.

Authors:  C D Chen; M E Huff; J Matteson; L Page; R Phillips; J W Kelly; W E Balch
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.